Detail akcie Becton Dickinson online

Business Summary: Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Financial Summary: BRIEF: For the nine months ended 30 June 2026, Becton Dickinson and Co revenues increased 4% to $14.95B. Net income applicable to common stockholders excluding extraordinary items decreased 13% to $796M. Revenues reflect Connected Care segment increase of 5% to $2.35B, BioPharma System segment increase of 5% to $1.26B, United States segment increase of 5% to $9.16B, International segment increase of 3% to $5.79B.